Valuation: Arcoma AB

Market Cap 11Cr 1.07Cr 95.84L 89.29L 81.25L 1.53Cr 103.46Cr 1.54Cr 4.2Cr 53Cr 4.03Cr 3.95Cr 169.73Cr P/E 2024
12.7x
P/E 2025 20.9x
Enterprise Value 7.27Cr 72.35L 64.54L 60.13L 54.72L 1.03Cr 70Cr 1.04Cr 2.83Cr 36Cr 2.72Cr 2.66Cr 114.31Cr EV / Sales 2024
0.82x
EV / Sales 2025 0.53x
Free-Float
57.91%
Yield 2024 *
-
Yield 2025 -
1 day+2.12%
1 week+4.62%
Current month+6.06%
1 month-2.53%
3 months-6.33%
6 months-5.41%
Current year+4.90%
1 week 6.9
Extreme 6.9
7.86
1 month 6.56
Extreme 6.56
8.34
Current year 6.16
Extreme 6.16
10.05
1 year 6.16
Extreme 6.16
10.05
3 years 6.16
Extreme 6.16
18.3
5 years 6.16
Extreme 6.16
18.3
10 years 3.57
Extreme 3.57
26.3
Manager TitleAgeSince
Chief Executive Officer 45 01/01/2023
Director of Finance/CFO - 15/08/2026
Chief Tech/Sci/R&D Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Chairman 54 01/01/2017
Director/Board Member 59 01/01/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+4.62%-15.94%+10.79% 1.07Cr
+3.35%-0.27%+24.56%+35.89% 25TCr
+3.34%-2.69%+2.89%+2.00% 16TCr
+3.71%-2.00%-10.14%+40.12% 14TCr
-0.47%-3.88%-56.43%-17.96% 6.14TCr
+2.44%+0.46%+13.18%+20.82% 5.03TCr
+1.16%-1.86%-21.50%-20.05% 4.67TCr
+2.09%-2.24%+20.93%+55.22% 4.83TCr
+3.70%+1.25%-4.33%+40.74% 4.59TCr
+3.51%-0.64%+34.02%+65.46% 4.32TCr
Average +2.49%-1.59%-1.28%+23.30% 8.45TCr
Weighted average by Cap. +2.91%-2.77%+4.27%+25.35%

Financials

2024 2025
Net sales 16Cr 1.56Cr 1.39Cr 1.3Cr 1.18Cr 2.22Cr 150.38Cr 2.24Cr 6.1Cr 77Cr 5.86Cr 5.74Cr 246.7Cr 13Cr 1.3Cr 1.16Cr 1.08Cr 98.51L 1.86Cr 125.44Cr 1.87Cr 5.09Cr 64Cr 4.89Cr 4.78Cr 205.78Cr
Net income 1.12Cr 11.13L 10L 9L 8L 15.86L 11Cr 15.97L 43.49L 5.47Cr 41.79L 40.89L 18Cr 50.3L 5L 4L 4L 4L 7L 4.82Cr 7L 19.57L 2.46Cr 18.8L 18.4L 7.91Cr
Net Debt -1.33Cr -13.26L -11.83L -11.02L -10.03L -18.89L -13Cr -19.03L -51.81L -6.52Cr -49.78L -48.71L -21Cr -3.52Cr -35.08L -31.29L -29.15L -26.53L -49.96L -34Cr -50.33L -1.37Cr -17Cr -1.32Cr -1.29Cr -55Cr
Logo Arcoma AB
Arcoma AB is a Sweden-based medical technology company. It develops, produces and markets digital radiographic systems. Its products offer digital imaging technology combined with advanced mobile positioning system. The Company's product portfolio comprises: complete radiographic systems available as ceiling suspensions and floor mounted systems, as well as detectors; radiographic system components, such as overhead tube crane, cube, tilting wall stand and radiographic tables; and mobile imaging tables in two series, namely Precision and Elite. Its products are designed for hospitals, clinics, imaging centers and private practices, and available through three market channels: its own brand IMIX, private label distributors and original equipment manufacturers (OEM).
Employees
33
Date Price Change Volume
06/26/06 SEK 7.700 +2.12% 1,00,178
05/26/05 SEK 7.540 +0.80% 1,526
02/26/02 SEK 7.480 +3.03% 8,700
30/26/30 SEK 7.260 -1.36% 184
29/26/29 SEK 7.360 +2.51% 15

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ARCOMA Stock